Penghui Wang

Penghui Wang

Auto-generated profile, based on publicly available information

Penghui Wang

State Key Laboratory of Materials-Oriented Chemical Engineering, College of Food Science and Light Industry, Nanjing Tech University, Nanjing, China

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SLShuai Liu
Shuai Liu
XLXin Liu
Xin Liu
YRYanhan Ren
Yanhan Ren
PWPeng Hui Wang
Peng Hui Wang
YPYajie Pu
Yajie Pu
BCBo Chi
Bo Chi

16 August 2017 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
PWPenghui Wang
Penghui Wang
XHXiaodong He
Xiaodong He
Representing a novel type of endogenous noncoding RNAs, circular RNAs (circRNAs) have recently gained much attention for their involvement in multiple biological processes. CircRNAs are ubiquitously expressed in eukaryotic cells and modulate gene expression by acting as sponges of microRNAs (miRNAs) or other proteins, such as RNA-binding proteins (RBPs). Due to their unique structure, circRNAs are more stable than linear RNAs. Expression profiles of circRNAs are associated with clinicopathological characteristics of colorectal cancer patients, such as differentiation, TNM classification and distant metastasis. Furthermore, circRNAs play crucial roles in multiple processes associated with malignant phenotypes, including cell proliferation/cycle, apoptosis and invasion. Improvements in RNA-sequencing methods have helped researchers to elucidate molecular interactions between circRNAs and colorectal cancer. This review provides a comprehensive overview of the features and functions of circRNAs, as well as insights into their roles in the onset and development of colorectal cancer. Combined with the reported results, the identification of circRNAs associated with colorectal cancer will certainly contribute to early detection and help to design treatment strategies for colorectal cancer. Screening for circRNAs may provide an accessible, noninvasive yet highly sensitive diagnosis for colorectal cancer. Furthermore, a better understanding of the roles of circRNAs may also provide a novel predictive feature in colorectal cancer therapy and prognosis.

10 June 2020 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
XMXuebin Ma
Xuebin Ma
XLXin Liu
Xin Liu
PWPenghui Wang
Penghui Wang
XWXiaoxue Wang
Xiaoxue Wang
RYRong Yang
Rong Yang
BCBo Chi
Bo Chi

11 November 2019 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
PWPenghui Wang
Penghui Wang
WLWei Liu
Wei Liu
SLShuai Liu
Shuai Liu
RYRong Yang
Rong Yang
YPYajie Pu
Yajie Pu
BCBO CHI
BO CHI
Here, a novel pH-responsive block copolymer, poly (ethylene glycol)-poly(ε-caprolactone)-poly(L-histidine) (PEG-PCL-PHis), was synthesized and designed for anti-cancer drug delivery with excellent biocompatible, biodegradable and strong drug loading efficiency. 1H-NMR, IF-IR and GPC were used to characterize the structure of the PEG-PCL-PHis copolymer. In addition, the morphology, particle size, Zeta potential, and critical micelle concentration (CMC) of different degree of polymerization were determined by transmission electron microscopy (TEM), dynamic light scattering granulometer (DLS), and fluorescence spectrometer, respectively. The strong affinity between the core of micelles and hydrophobic drug was manifested with 15.09% drug loading content and 84.65% entrapment efficiency. In vitro release of DOX from the block copolymer micelle demonstrated, the PEG-PCL-PHis copolymer micelle has stable and durable drug releasing ability accompanied with pH-sensitivity. From the mechanism of cellular uptake the micelles, the pathway of drug release was captured by confocal laser scanning microscope. These experiments demonstrated the safe delivery for anticancer medicine through this novel copolymer. In conclusion, the PEG-PCL-PHis copolymer micelle has great potential to become a safe drug carrier for cancer chemotherapy.

18 July 2020 in Journal of Bioactive and Compatible Polymers
Verified
Journal Article
Closed access
PDF file
PWPenghui Wang
Penghui Wang
RYRong Yang
Rong Yang
SLShuai Liu
Shuai Liu
YRYanhan Ren
Yanhan Ren
XLXin Liu
Xin Liu
BCBo Chi
Bo Chi
Transmembrane delivery of biomolecules through nanoparticles plays an important role in targeted therapy. Here, we designed a simple nanoparticle for the delivery of model peptide drug into primary osteoclast precursor cells (bone marrow macrophages) by thermosensitive and biodegradable diblock copolymer monomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate). The model peptide drug was encapsulated into the nanoparticle by dropping the drug carrier dissolved in dimethylsulfoxide solvent into water containing poly(vinyl alcohol) to achieve temperature response nanoparticles. Through size analysis, we found that the nanoparticles possessed a temperature-sensitive property between 30°C and 40°C. Moreover, flow cytometry and spectrofluorimetry analysis indicated that nanoparticle systems underwent significant cellular uptake. In addition, the evaluation of cell biology showed that nanoparticles have excellent biocompatibility. Thus, the results indicated that the temperature-sensitive nanoparticles have potential application value for targeted delivery of oligopeptide in the treatment process of osteoarthritis.

2 August 2023 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
WCWei-Ting Chao
Wei-Ting Chao
PWPeng-Hui Wang
Peng-Hui Wang
HHuann-Cheng Horng
Huann-Cheng Horng